Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 176

1.

Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma.

Schmidt J, Abel U, Debus J, Harig S, Hoffmann K, Herrmann T, Bartsch D, Klein J, Mansmann U, Jäger D, Capussotti L, Kunz R, Büchler MW.

J Clin Oncol. 2012 Nov 20;30(33):4077-83. doi: 10.1200/JCO.2011.38.2960. Epub 2012 Sep 24.

PMID:
23008325
[PubMed - indexed for MEDLINE]
Free Article
2.

Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759].

Knaebel HP, Märten A, Schmidt J, Hoffmann K, Seiler C, Lindel K, Schmitz-Winnenthal H, Fritz S, Herrmann T, Goldschmidt H, Krempien R, Mansmann U, Debus J, Diehl V, Büchler MW.

BMC Cancer. 2005 Apr 12;5:37.

PMID:
15826316
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2.

Märten A, Schmidt J, Ose J, Harig S, Abel U, Münter MW, Jäger D, Friess H, Mayerle J, Adler G, Seufferlein T, Gress T, Schmid R, Büchler MW.

BMC Cancer. 2009 May 26;9:160. doi: 10.1186/1471-2407-9-160.

PMID:
19470159
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031.

Picozzi VJ, Abrams RA, Decker PA, Traverso W, O'Reilly EM, Greeno E, Martin RC, Wilfong LS, Rothenberg ML, Posner MC, Pisters PW; American College of Surgeons Oncology Group.

Ann Oncol. 2011 Feb;22(2):348-54. doi: 10.1093/annonc/mdq384. Epub 2010 Jul 29.

PMID:
20670978
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial.

Arkenau HT, Bermann A, Rettig K, Strohmeyer G, Porschen R; Arbeitsgemeinschaft Gastrointestinale Onkologie.

Ann Oncol. 2003 Mar;14(3):395-9.

PMID:
12598344
[PubMed - indexed for MEDLINE]
Free Article
6.

[Interferon-alpha in adjuvant treatment of colorectal carcinoma].

Staib L, Link KH, Henne-Bruns D.

Kongressbd Dtsch Ges Chir Kongr. 2002;119:142-5. German.

PMID:
12704877
[PubMed - indexed for MEDLINE]
7.

Interferon-alpha does not improve the antineoplastic efficacy of high-dose infusional 5-fluorouracil plus folinic acid in advanced colorectal cancer. First results of a randomized multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO).

Köhne CH, Wilke H, Hecker H, Schöffski P, Käufer C, Rauschecker H, Andreesen R, Ohl U, Lange HJ, Klaassen U, et al.

Ann Oncol. 1995 May;6(5):461-6.

PMID:
7669711
[PubMed - indexed for MEDLINE]
8.

Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma.

Landry J, Catalano PJ, Staley C, Harris W, Hoffman J, Talamonti M, Xu N, Cooper H, Benson AB 3rd.

J Surg Oncol. 2010 Jun 1;101(7):587-92. doi: 10.1002/jso.21527.

PMID:
20461765
[PubMed - indexed for MEDLINE]
9.

Survival and quality of life of patients with resected pancreatic adenocarcinoma treated with adjuvant interferon-based chemoradiation: a phase II trial.

Katz MH, Wolff R, Crane CH, Varadhachary G, Javle M, Lin E, Evans DB, Lee JE, Fleming JB, Pisters PW.

Ann Surg Oncol. 2011 Dec;18(13):3615-22. doi: 10.1245/s10434-011-1847-4. Epub 2011 Jun 24.

PMID:
21701927
[PubMed - indexed for MEDLINE]
10.

Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.

Fountzilas G, Zisiadis A, Dafni U, Konstantaras C, Hatzitheoharis G, Papavramidis S, Bousoulegas A, Basdanis G, Giannoulis E, Dokmetzioglou J, Katsohis C, Nenopoulou E, Karvounis N, Briassoulis E, Aravantinos G, Kosmidis P, Skarlos D, Pavlidis N.

Oncology. 2000 Apr;58(3):227-36.

PMID:
10765125
[PubMed - indexed for MEDLINE]
11.

A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma.

Ducreux M, Rougier P, Pignon JP, Douillard JY, Seitz JF, Bugat R, Bosset JF, Merouche Y, Raoul JL, Ychou M, Adenis A, Berthault-Cvitkovic F, Luboinski M; Groupe Digestif of the Fédération Nationale des Centres de Lutte Contre le Cancer Digestif.

Ann Oncol. 2002 Aug;13(8):1185-91.

PMID:
12181240
[PubMed - indexed for MEDLINE]
Free Article
12.

Toxicity and effects of adjuvant therapy in colon cancer: results of the German prospective, controlled randomized multicenter trial FOGT-1.

Staib L, Link KH, Beger HG; Members of the Forschungsgruppe Onkologie Gastrointestinaler Tumoren (FOGT).

J Gastrointest Surg. 2001 May-Jun;5(3):275-81.

PMID:
11419451
[PubMed - indexed for MEDLINE]
13.
14.

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.

Neoptolemos JP, Stocken DD, Bassi C, Ghaneh P, Cunningham D, Goldstein D, Padbury R, Moore MJ, Gallinger S, Mariette C, Wente MN, Izbicki JR, Friess H, Lerch MM, Dervenis C, Oláh A, Butturini G, Doi R, Lind PA, Smith D, Valle JW, Palmer DH, Buckels JA, Thompson J, McKay CJ, Rawcliffe CL, Büchler MW; European Study Group for Pancreatic Cancer.

JAMA. 2010 Sep 8;304(10):1073-81. doi: 10.1001/jama.2010.1275.

PMID:
20823433
[PubMed - indexed for MEDLINE]
15.

Randomized multicenter phase II trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2), LV5FU2 plus cisplatin, or LV5FU2 plus irinotecan in patients with previously untreated metastatic gastric cancer: a Federation Francophone de Cancerologie Digestive Group Study--FFCD 9803.

Bouché O, Raoul JL, Bonnetain F, Giovannini M, Etienne PL, Lledo G, Arsène D, Paitel JF, Guérin-Meyer V, Mitry E, Buecher B, Kaminsky MC, Seitz JF, Rougier P, Bedenne L, Milan C; Fédération Francophone de Cancérologie Digestive Group.

J Clin Oncol. 2004 Nov 1;22(21):4319-28.

PMID:
15514373
[PubMed - indexed for MEDLINE]
Free Article
16.

Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO.

Kollmannsberger C, Budach W, Stahl M, Schleucher N, Hehr T, Wilke H, Schleicher J, Vanhoefer U, Jehle EC, Oechsle K, Trarbach T, Boehlke I, Kanz L, Hartmann JT, Bokemeyer C.

Ann Oncol. 2005 Aug;16(8):1326-33. Epub 2005 May 26.

PMID:
15919686
[PubMed - indexed for MEDLINE]
Free Article
17.

Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.

Nukui Y, Picozzi VJ, Traverso LW.

Am J Surg. 2000 May;179(5):367-71.

PMID:
10930481
[PubMed - indexed for MEDLINE]
18.

Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.

Chakravarthy A, Abrams RA, Yeo CJ, Korman LT, Donehower RC, Hruban RH, Zahurek ML, Grochow LB, O'Reilly S, Hurwitz H, Jaffee EM, Lillemoe KD, Cameron JL.

Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1089-96.

PMID:
11072167
[PubMed - indexed for MEDLINE]
19.

Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.

Picozzi VJ, Kozarek RA, Traverso LW.

Am J Surg. 2003 May;185(5):476-80.

PMID:
12727570
[PubMed - indexed for MEDLINE]
20.

Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trial.

Reni M, Balzano G, Aprile G, Cereda S, Passoni P, Zerbi A, Tronconi MC, Milandri C, Saletti P, Rognone A, Fugazza C, Magli A, Di Muzio N, Di Carlo V, Villa E.

Ann Surg Oncol. 2012 Jul;19(7):2256-63. doi: 10.1245/s10434-011-2205-2. Epub 2012 Jan 12.

PMID:
22237835
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk